46 results
IDSA Recommended antimicrobial regimens for treatment of patients with Lyme disease.

#Management #InfectiousDiseases #Antibiotics #LymeDisease #Treatment #Regimens
IDSA Recommended ... patients with Lyme disease ... #Management #InfectiousDiseases ... #LymeDisease #Treatment ... #Regimens #IDSA
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Clinical Disease ... clinical manifestation ... Trypanosomiasis #IDSA ... #Prevention #Treatment
This is an oversimplified, hypothetical model to think about time from symptom onset and stages of
and stages of disease ... determine what treatments ... COVID19 #COVID #infectiousdisease ... #clinical #management ... #treatment
IDSA Recommended therapy for patients with Lyme disease.

#Management #InfectiousDiseases #Antibiotics #LymeDisease #Treatment #Regimens #Duration #IDSA
IDSA Recommended ... patients with Lyme disease ... #Management #InfectiousDiseases ... #LymeDisease #Treatment ... Regimens #Duration #IDSA
Table 3. Suggested Empiric Treatment Options for Clinically Suspected Ventilator-Associated Pneumonia in Units Where Empiric Methicillin-Resistant
Table 3. ... Suggested Empiric Treatment ... Options for Clinically ... Appropriate #Management #InfectiousDiseases
Common Biliary Diseases seen in the Emergency Room - Comparison Table:

Clinical Features, Labs, Imaging and Treatment

#Diagnosis
Common Biliary Diseases ... Room - Comparison Table ... : Clinical Features ... Labs, Imaging and Treatment ... BiliaryDiseases #Table
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... candida #mucosal #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... for Preventing ... recommended for KS treatment ... KaposiSarcoma #Castlemans #IDSA ... #Prevention #Treatment
Summary of actions of some Cholinergic Agonists

Bethanechol 
• Used in treatment of urinary retention 
• Binds
Bethanechol • Used in treatment ... of urinary retention ... for Alzheimer's disease ... moderate to severe disease ... #Pharmacology #Table
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
GrepMed Handbook Clinical ... Tx Management (IDSA ... /severe CDI IDSA ... 2021 CDI Treatment ... #infectiousdiseases